Methods for treating apolipoprotein E4-associated disorders
Abstract:
The present disclosure provides a method of increasing the functionality of a GABAergic interneuron in the hilus of the hippocampus of an individual having at least one apolipoprotein E4 (apoE4) allele. The method generally involves reducing tau levels in the interneuron.
Public/Granted literature
Information query
Patent Agency Ranking
0/0